Abstract

Regenerative medicine has the promise to alleviate morbidity and mortality caused by organ dysfunction, longstanding injury and trauma. Although regenerative approaches for a few diseases have been highly successful, some organs either do not regenerate well or have no current treatment approach to harness their intrinsic regenerative potential. In this Review, we describe the modeling of human disease and tissue repair in zebrafish, through the discovery of disease-causing genes using classical forward-genetic screens and by modulating clinically relevant phenotypes through chemical genetic screening approaches. Furthermore, we present an overview of those organ systems that regenerate well in zebrafish in contrast to mammalian tissue, as well as those organs in which the regenerative potential is conserved from fish to mammals, enabling drug discovery in preclinical disease-relevant models. We provide two examples from our own work in which the clinical translation of zebrafish findings is either imminent or has already proven successful. The promising results in multiple organs suggest that further insight into regenerative mechanisms and novel clinically relevant therapeutic approaches will emerge from zebrafish research in the future.

Highlights

  • Regenerative medicine offers the promise of regaining organ function after acute or chronic injury

  • Intensive research is focused on the discovery and isolation of specialized cell types, or small molecules that can boost the innate ability of the human body to achieve endogenous regenerative repair for a variety of tissues; significant effort is likewise being put forth to develop methods to stimulate repair in organ systems in which no intrinsic regenerative process is currently evident in humans

  • After screening ~2500 compounds, this study revealed a number of relevant hematopoietic stem cell (HSC) regulators, including prostaglandin E2 (PGE2) and nitric oxide (NO) (North et al, 2009), both of which showed strong conservation of effect in vitro and in vivo across vertebrate species, in developmental regulation and organ regeneration

Read more

Summary

Introduction

Regenerative medicine offers the promise of regaining organ function after acute or chronic injury. All these investigations revealed several genes that affect organ development, function and/or susceptibility to disease; this information can be used to conduct further chemical and/or genetic interaction or suppressor screens in zebrafish or to guide follow-up studies in mammalian models.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call